EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9 | -25.0% | 1,672 | -25.3% | 0.00% | – |
| Q1 2024 | $12 | -47.8% | 2,237 | -48.2% | 0.00% | – |
| Q4 2023 | $23 | +35.3% | 4,322 | +306.2% | 0.00% | – |
| Q3 2023 | $17 | +54.5% | 1,064 | +83.4% | 0.00% | – |
| Q2 2023 | $11 | +175.0% | 580 | +360.3% | 0.00% | – |
| Q1 2023 | $4 | -42.9% | 126 | -46.6% | 0.00% | – |
| Q4 2022 | $7 | -99.8% | 236 | +40.5% | 0.00% | – |
| Q3 2022 | $4,000 | – | 168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |